Differing perspectives among gastric motility experts and regulatory roadblocks impede clinical care, but some companies are ...
Abivax is advancing obefazimod, a first-in-class oral therapy for UC and CD, with major upcoming data catalysts. Click here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results